ELC Group Appoints Dr. Siddharth Chachad as Head of Global Clinical Development and Medical Affairs

Cambridge, UK, 20 August, 2014: ELC Group, one of the fastest-growing providers of regulatory affairs, today announces the appointment of internationally acclaimed clinical pharmacologist Dr. Siddharth Chachad as Head of Global Clinical Development and Medical Affairs. A member of the UK Faculty of Pharmaceutical Medicine, Dr. Chachad is an expert in the design and execution of pre-clinical and clinical development programme for drug products across dosage forms and therapeutic categories. Dr. Chachad has gained considerable career experience in the delivery medical services, medico-regulatory affairs and clinical development, and has worked across global clinical development strategy and operations of generics, new drugs and biosimilars. Dr. Siddharth’s extensive expertise covers all phases of clinical studies, including pre-clinical, pharmacodynamic studies, bioequivalence, PK in patients and full-blown clinical efficacy and safety studies.

For more information read the full news release here:
http://www.neondrum.com/public/public_release.php?id=1753

Forums:

Speciality: